These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11165816

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H, Bodmeier R.
    Int J Pharm; 2007 Mar 06; 332(1-2):107-14. PubMed ID: 17084049
    [Abstract] [Full Text] [Related]

  • 4. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H, Bodmeier R.
    Eur J Pharm Sci; 2008 Jul 03; 34(2-3):164-72. PubMed ID: 18501569
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems.
    Dong WY, Körber M, López Esguerra V, Bodmeier R.
    J Control Release; 2006 Oct 10; 115(2):158-67. PubMed ID: 16963145
    [Abstract] [Full Text] [Related]

  • 13. In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery.
    Brazeau GA, Attia S, Poxon S, Hughes JA.
    Pharm Res; 1998 May 10; 15(5):680-4. PubMed ID: 9619774
    [Abstract] [Full Text] [Related]

  • 14. A novel injectable in situ forming poly-DL-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug delivery.
    Yehia SA, Elshafeey AH, Elsayed I.
    J Liposome Res; 2012 Jun 10; 22(2):128-38. PubMed ID: 22091557
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In situ gel formulations for gene delivery: release and myotoxicity studies.
    Ismail FA, Napaporn J, Hughes JA, Brazeau GA.
    Pharm Dev Technol; 2000 Jun 10; 5(3):391-7. PubMed ID: 10934739
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium.
    Kohane DS, Lipp M, Kinney RC, Anthony DC, Louis DN, Lotan N, Langer R.
    J Biomed Mater Res; 2002 Mar 05; 59(3):450-9. PubMed ID: 11774302
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.